EX-99.1 2 f8k111319ex99-1_cyrenltd.htm PRESS RELEASE OF CYREN LTD. DATED NOVEMBER 13, 2019

Exhibit 99.1

 

 

 

PRESS RELEASE

 

Cyren Announces Third Quarter 2019 Financial Results

- - -

Year-to-date revenue up 9% despite slight revenue decline during quarter

 

McLean, Va. – November 13, 2019 – Cyren (NASDAQ: CYRN) today announced its third quarter 2019 financial results for the period ending September 30, 2019.

 

During the third quarter, Cyren reported quarterly revenues of $9.5 million, compared to $9.6 million during the third quarter of 2018. For the first three quarters of 2019, year-to-date revenues were $28.9 million, which represents a 9% annual increase over the first three quarters of 2018.

 

GAAP net loss for the quarter was $3.5 million, compared to $4.4 million during the third quarter of 2018. Year-to-date, net loss declined to $12.7 million compared to a net loss of $13.8 million over the same period a year ago.

 

“Our top priority is driving more aggressive growth and we are refining our strategy to take advantage of the market opportunities we see,” said Brett Jackson, CEO of Cyren. “Our team has made very good progress over the past several months and are now very focused on execution. We expect to begin seeing the benefits from our key initiatives emerging over the next several quarters.”

 

Third Quarter 2019 Financial Highlights:

 

●Revenues for the third quarter of 2019 were $9.5 million, compared to $9.6 million during the third quarter of 2018.

 

●GAAP net loss for the third quarter of 2019 was $3.5 million, compared to a net loss of $4.4 million in the third quarter of 2018.

 

●GAAP loss per basic and diluted share for the third quarter of 2019 was $0.06, compared to a loss of $0.08 per basic and diluted share for the third quarter of 2018.

 

●Non-GAAP net loss for the third quarter of 2019 was $3.5 million, compared to a Non-GAAP net loss of $3.3 million for the third quarter of 2018.

 

●Non-GAAP loss per basic and diluted share was $0.06 for the third quarter of 2019, compared to a Non-GAAP loss of $0.06 per share in third quarter of 2018.

 

·Cash used in operating activities during the third quarter of 2019 was $1.7 million, compared to operating cash usage of $2.6 million during the third quarter of 2018.

 

 

 

 

●Net cash flow for the third quarter of 2019 was negative $2.9 million, compared to negative $3.1 million during the third quarter of 2018.

 

●Cash balance as of September 30, 2019, was $9.5 million, compared to $17.6 million as of December 31, 2018. This does not include the proceeds of the Rights Offering detailed below.

 

For information regarding the non-GAAP financial measures discussed in this release, please see “Use of Non-GAAP Financial Measures” and “Reconciliation of Selected GAAP Measures to Non-GAAP Measures.”

 

Rights Offering:

 

During the third quarter, Cyren announced a Rights Offering to shareholders of record as of September 25. Right holders were entitled to purchase one ordinary share at a subscription price of $1.73 per share. The Rights Offering closed on November 6, 2019 and generated approximately $8 million of gross proceeds to Cyren, which is not reflected in the September 30, 2019 cash balance. Pursuant to the Rights Offering, Cyren issued a total of 4,635,584 ordinary shares at $1.73 per share, including 4,624,277 shares issued to the company’s majority shareholder, WP XII Investments B.V., an entity controlled by funds affiliated with Warburg Pincus. After the offering, Cyren now has 59,319,391 shares outstanding.

 

Financial Results Conference Call:

 

The company will host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, November 13, 2019 to discuss third quarter results.

 

U.S. Dial-in Number:   1-877-407-0312
Israel Dial-in Number:   1-80-940-6247
International Dial-in Number:   1-201-389-0899

 

The call will be simultaneously webcast live on the investor relations section of Cyren’s website at https://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20191113/.

 

For those unable to participate in the live conference call, a replay will be available until November 27, 2019. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13696074. An archived version of the webcast will also be available on the investor relations section of the company’s website at https://ir.cyren.com/events.

 

About Cyren:

 

More than 1.3 billion users around the world rely on Cyren’s 100% cloud security solutions to protect them against cyber attacks and data loss every day. Powered by the world’s largest security cloud, Cyren (NASDAQ: CYRN) delivers fast time-to-protection with award-winning email security, cloud sandboxing and DNS filtering services for business, and threat intelligence solutions for service providers and security vendors like Microsoft, Google and Check Point. Learn more at www.cyren.com.

 

Blog: http://blog.cyren.com

Facebook: www.facebook.com/CyrenWeb

LinkedIn: www.linkedin.com/company/cyren

Twitter: www.twitter.com/CyrenInc

 

2 

 

 

Use of Non-GAAP Financial Measures:

 

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets, and deferred taxes related to acquisitions, adjustments to earn-out obligations, and capitalization of technology. The purpose of such adjustments is to give an indication of the company’s performance exclusive of non-cash charges and other items that are considered by management to be outside of the company’s core operating results. The company’s non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP.

 

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

 

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company’s current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

 

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as “expect,” “plan,” “estimate,” “anticipate,” or “believe” are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including our CEO transition, business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company’s publicly filed reports, which are available through www.sec.gov.

 

Company Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com

 

3 

 

 

CYREN LTD.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(in thousands of U.S. dollars, except per share amounts)

 

   Three months ended   Nine months ended 
   September 30   September 30 
   2019   2018   2019   2018 
   Unaudited   Unaudited   Unaudited   Unaudited 
                 
Revenues  $9,496   $9,562   $28,862   $26,388 
                     
Cost of revenues   3,712    3,670    11,501    10,684 
                     
Gross profit   5,784    5,892    17,361    15,704 
                     
Operating expenses:                    
                     
Research and development, net   3,516    4,336    11,990    11,355 
                     
Sales and marketing   3,027    3,931    10,473    12,133 
                     
General and administrative   2,484    2,166    7,314    6,151 
                     
Total operating expenses   9,027    10,433    29,777    29,639 
                     
Operating loss   (3,243)   (4,541)   (12,416)   (13,935)
                     
Other income (expense), net   (3)   -    262    (17)
                     
Financial income (expense), net   (321)   7    (642)   (91)
                     
Loss before taxes   (3,567)   (4,534)   (12,796)   (14,043)
                     
Tax benefit   37    107    117    201 
                     
Net loss  $(3,530)  $(4,427)  $(12,679)  $(13,842)
                     
Loss per share - basic and diluted  $(0.06)  $(0.08)  $(0.23)  $(0.26)
                     
Weighted average number of shares outstanding:                    
Basic and Diluted   54,554    53,679    54,389    53,503 

 

4 

 

 

CYREN LTD.

 

RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES

 

(in thousands of U.S.dollars, except per share amounts)

 

   Three months ended   Nine months ended 
   September 30   September 30 
   2019   2018   2019   2018 
   Unaudited   Unaudited   Unaudited   Unaudited 
                 
GAAP gross profit  $5,784   $5,892   $17,361   $15,704 
GAAP gross margin   61%   62%   60%   60%
Plus:                    
Stock-based compensation   36    48    98    124 
Amortization of intangible assets   758    907    2,364    2,692 
Non-GAAP gross profit   6,578    6,847    19,823    18,520 
Non-GAAP gross margin   69%   72%   69%   70%
                     
GAAP operating loss   (3,243)   (4,541)   (12,416)   (13,935)
Plus:                    
Stock-based compensation   419    358    1,002    1,031 
Amortization of intangible assets   883    1,060    2,736    3,157 
Capitalization of technology   (1,118)   (242)   (2,510)   (1,886)
Non-GAAP operating loss   (3,059)   (3,365)   (11,188)   (11,633)
                     
GAAP net loss   (3,530)   (4,427)   (12,679)   (13,842)
Plus:                    
Stock-based compensation expense   419    358    1,002    1,031 
Intangible amortization expense   883    1,060    2,736    3,157 
Adjustment to earn-out liabilities   -    23    -    75 
Amortization of deferred tax assets   (55)   (62)   (170)   (188)
Gain from an earn-out liability settlement   -    -    (256)   - 
Capitalization of technology   (1,169)   (242)   (2,627)   (1,886)
Non-GAAP net loss  $(3,452)  $(3,290)  $(11,994)  $(11,653)
                     
Numerator for non-GAAP EPS calculation  $(3,452)  $(3,290)  $(11,994)  $(11,653)
Non-GAAP net loss per share  $(0.06)  $(0.06)  $(0.22)  $(0.22)
                     
GAAP weighted-average shares used to compute net loss per share   54,554    53,679    54,389    53,503 

 

5 

 

 

CYREN LTD.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(in thousands of U.S. dollars)

 

   September 30   December 31 
   2019   2018 
   Unaudited   Audited 
Assets        
Current Assets:        
Cash and cash equivalents  $9,546   $17,571 
Trade receivables, net   3,499    3,658 
Deferred commissions   930    887 
Prepaid expenses and other receivables   1,329    778 
Total current assets   15,304    22,894 
           
Long-term deferred commissions   1,646    1,880 
Long-term lease deposits   782    821 
Operating lease right-of-use assets   8,974    - 
Severance pay fund   610    503 
Property and equipment, net   4,437    4,608 
Intangible assets, net   8,667    8,802 
Goodwill   19,904    20,519 
Total long-term assets   45,020    37,133 
Total assets  $60,324   $60,027 
           
Liabilities and Shareholders’ Equity          
Current Liabilities:          
Trade payables  $1,402   $1,668 
Employees and payroll accruals   3,690    3,959 
Accrued expenses and other liabilities   1,421    910 
Operating lease liabilities   1,298    - 
Earn-out consideration   -    2,926 
Deferred revenues   9,270    5,773 
Total current liabilities   17,081    15,236 
           
Deferred revenues   2,944    503 
Convertible notes   10,000    10,000 
Long-term operating lease liabilities   7,993    - 
Deferred tax liability   912    1,130 
Accrued severance pay   778    598 
Other liabilities   337    700 
Total long-term liabilities   22,964    12,931 
           
Shareholders’ equity   20,279    31,860 
Total liabilities and shareholders’ equity  $60,324   $60,027 

 

6 

 

 

CONDENSED CONSOLIDATED CASH FLOW DATA

 

(in thousands of U.S. dollars)

 

   Three months ended   Nine months ended 
   September 30   September 30 
   2019   2018   2019   2018 
   Unaudited   Unaudited   Unaudited   Unaudited 
Cash flows from operating activities:                
                 
Net loss  $(3,530)  $(4,427)  $(12,679)  $(13,842)
                     
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:           
Loss on disposal of property and equipment   -    -    1    14 
Depreciation   484    438    1,420    1,434 
Stock-based compensation   419    358    1,002    1,031 
Amortization of intangible assets   885    1,060    2,736    3,157 
Amortization of deferred commissions   (297)   445    (909)   1,005 
Amortization of operating lease right-of-use assets   338    -    1,051    - 
Interest on convertible notes   142    -    424    - 
Other expenses (income) related to the earn-out consideration   -    23    (257)   75 
Deferred taxes, net   (55)   (57)   (182)   (152)
                     
Changes in assets and liabilities:                    
Trade receivables   (509)   (607)   196    (292)
Prepaid expenses and other receivables   168    306    (607)   (392)
Deferred commissions   353    (954)   1,101    (1,797)
Change in long-term lease deposits   2    5    25    (110)
Trade payables   559    375    (264)   306 
Employees and payroll accruals, accrued expenses and other liabilities   39    346    (185)   677 
Deferred revenues   (357)   110    5,997    3,040 
Accrued severance pay, net   5    21    73    (120)
Operating lease liabilities   (342)   -    (1,075)   - 
Other long-term liabilities   (15)   1    (126)   71 
Net cash provided by (used in) operating activities   (1,711)   (2,557)   (2,258)   (5,895)
                     
Cash flows from investing activities:                    
                     
Proceeds from sale of property and equipment   1    -    1    - 
Capitalization of technology, net of grants received   (1,027)   (384)   (2,462)   (1,844)
Purchase of property and equipment   (309)   (1,156)   (1,259)   (2,989)
Net cash used in investing activities   (1,335)   (1,540)   (3,720)   (4,833)
                     
Cash flows from financing activities:                    
                     
Payment of earnout liability   -    -    (2,680)   (604)
Proceeds from options exercised   231    984    743    1,276 
Net cash provided by (used in) financing activities   231    984    (1,937)   672 
Effect of exchange rate changes on cash   (76)   12    (124)   (39)
Increase (decrease) in cash, cash equivalents and restricted cash   (2,891)   (3,101)   (8,039)   (10,095)
Cash, cash equivalents and restricted cash at the beginning of the period   13,008    17,234    18,156    24,228 
Cash, cash equivalents and restricted cash at the end of the period  $10,117   $14,133   $10,117   $14,133 
                     
Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow:                    
Cash and cash equivalents  $9,546   $13,527   $9,546   $13,527 
Restricted cash included in long-term restricted lease deposits   571    606    571    606 
                     
Total cash, cash equivalents and restricted cash  $10,117   $14,133   $10,117   $14,133 

 

 

7